Diabetes drug metformin tested in kidney patients – could change treatment guidelines
NCT ID NCT02710448
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This study looked at whether the common diabetes drug metformin can be used safely in people with kidney failure. Researchers gave increasing doses of metformin to 82 diabetic patients with various stages of kidney disease and measured drug levels in their red blood cells. The goal was to see if these levels stayed within a safe range, which could help guide future use of metformin in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service d'Endocrinologie, Maladies Métaboliques et Nutrition
Amiens, 80054, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Metformin
What this could lead to
If successful, this could help doctors safely prescribe metformin to diabetic patients with kidney disease, expanding treatment options.
What could go wrong
This is a small, early-phase study (82 participants) focused on drug levels, not long-term safety or outcomes. Results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.